Literature DB >> 27100352

Possible role of apolipoprotein A1 in healing and cell death after neuronal injury.

Mohor B Sengupta1, Debashis Mukhopadhyay2.   

Abstract

Limited axonal regeneration after traumatic injuries to the CNS presents a challenge in neuroscience. Investigation of CSF from subjects with spinal cord injury (SCI) has found that the lipid catabolism pathway is implicated in the post injury scenario. Sequestration of the CNS by the blood brain barrier ensures a mechanism of cholesterol metabolism and recycling distinct from that in the peripheral tissues. Apolipoprotein A1, the protein component of high density lipoprotein (HDL), is an abundant protein in the mammalian cerebrospinal fluid. Interaction of ApoA1 with its cellular receptor, ABCA1, gives rise to several signaling events, such as the activation of Cdc42 protein leading to actin polymerisation. Emerging evidences suggest that ApoA1 mediates anti-inflammatory effects and conversely, is negatively regulated by inflammatory cytokines. Collating these findings, added to the clinical evidences of using HDL as a therapeutic target for cardio vascular diseases, we hypothesize that ApoA1 could be useful in neurite outgrowth after mechanical injury by 1) mediating polymerisation of actin and 2) restricting inflammatory responses after injury which are deleterious to healing.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27100352     DOI: 10.2741/e780

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  6 in total

Review 1.  HDL as Bidirectional Lipid Vectors: Time for New Paradigms.

Authors:  María Luna-Luna; Eric Niesor; Óscar Pérez-Méndez
Journal:  Biomedicines       Date:  2022-05-20

2.  Nusinersen Modulates Proteomics Profiles of Cerebrospinal Fluid in Spinal Muscular Atrophy Type 1 Patients.

Authors:  Laura Bianchi; Maria Sframeli; Lorenza Vantaggiato; Gian Luca Vita; Annamaria Ciranni; Francesca Polito; Rosaria Oteri; Eloisa Gitto; Fabrizio Di Giuseppe; Stefania Angelucci; Antonio Versaci; Sonia Messina; Giuseppe Vita; Luca Bini; M'hammed Aguennouz
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

Review 3.  ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease.

Authors:  Maria Fe Lanfranco; Christi Anne Ng; G William Rebeck
Journal:  Int J Mol Sci       Date:  2020-09-01       Impact factor: 5.923

4.  Validation of serum apolipoprotein A1 in rabies virus-infected mice as a biomarker for the preclinical diagnosis of rabies.

Authors:  Kentaro Yamada; Koji Kuribayashi; Naotaka Inomata; Kazuko Noguchi; Kazunori Kimitsuki; Catalino S Demetria; Nobuo Saito; Satoshi Inoue; Chun-Ho Park; Ryo Kaimori; Motoi Suzuki; Mariko Saito-Obata; Yasuhiko Kamiya; Daria L Manalo; Beatriz P Quiambao; Akira Nishizono
Journal:  Microbiol Immunol       Date:  2021-08-03       Impact factor: 2.962

5.  Isobaric Tagging for Relative and Absolute Protein Quantification (iTRAQ)-Based Quantitative Proteomics Analysis of Differentially Expressed Proteins 1 Week After Spinal Cord Injury in a Rat Model.

Authors:  Shen Liu; Yi Kang; Chi Zhang; Yongfu Lou; Xueying Li; Lu Lu; Zhangyang Qi; Huan Jian; Hengxing Zhou
Journal:  Med Sci Monit       Date:  2020-11-04

6.  Apolipoprotein A-I in mouse cerebrospinal fluid derives from the liver and intestine via plasma high-density lipoproteins assembled by ABCA1 and LCAT.

Authors:  Maki Tsujita; Boris Vaisman; Liu Chengyu; Kasey C Vickers; Kei-Ichiro Okuhira; Sten Braesch-Andersen; Alan T Remaley
Journal:  FEBS Lett       Date:  2020-10-20       Impact factor: 4.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.